Patient Assistance Programs—A New Era of Law and Policy
JAMA · 2024
DOI: 10.1001/jama.2024.13162 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, 2024. Verfasst von C Joseph Ross Daval und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Wo…. Hauptthemen laut MEDLINE: Medical Assistance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint from authors at PORTAL discusses the importance of patient assistance programs in covering the cost of prescription drugs, highlights 2 recent rulings that illustrate the substantial barriers to regulating these programs, and calls for continued evaluation of these programs’ effectiveness and costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Daval, C. J. R., & Kesselheim, A. S. (2024). Patient Assistance Programs—A New Era of Law and Policy. JAMA. https://doi.org/10.1001/jama.2024.13162
Vancouver
Daval CJR, Kesselheim AS. Patient Assistance Programs—A New Era of Law and Policy. JAMA. 2024. doi:10.1001/jama.2024.13162
BibTeX
@article{Daval2024,
author = {Daval, C Joseph Ross and Kesselheim, Aaron S},
title = {Patient Assistance Programs—A New Era of Law and Policy},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.13162}
}
EUVIMED